ArticleScientific reports2025
Decoding the relationships among miRNA, HPV infection, and tumor suppressor gene expression in breast cancer patients.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Transcriptional modulation of the PI3K/AKT/mTOR signaling pathway mediated by HPV16Exploration of targeted anti-tumor therapy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast cancer (BC) is one of the main causes of cancer-related deaths among women, with its incidence rising due to various risk factors (RFs), including viral infections such as Human Papillomavirus (HPV). This study investigates the correlation between HPV infection and the expression levels of key cellular genes, TP53, PTEN, and CCND1, as well as specific microRNAs (miR-106b-5p, miR-17-5p, and miR-20a-5p) in 102 breast cancer patients and 41 healthy controls. Results indicated a higher prevalence of HPV in BC samples; however, the difference in prevalence between BC and control groups was not statistically significant. Importantly, TP53 and CCND1 were significantly overexpressed in BC, while PTEN was down regulated. The expression levels of CCND1 in HPV-positive BC group was also increased. Further analysis revealed that miR-106b-5p and miR-20a-5p were expressed at elevated levels in HPV-positive BC patients in comparison to their HPV-negative counterparts. All of considered miRNAs were overexpressed in BC group. By using receiver operating characteristic (ROC) analysis, CCND1, plus TP53 and miR-20a-5p emerged as biomarkers for breast cancer diagnosis and differentiation of HPV status respectively. A weak negative correlation between PTEN and three miRNAs, and weak positive correlations between CCND1 and miR-106b-5p and also TP53 and miR-20a-5p were observed. These findings emphasize the potential role of HPV and related biomarkers in the progression of breast cancer, indicating avenues for further research and therapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.